Navigation Links
AGI Dermatics President to be Keynote Speaker at the 11th Annual Sunscreen Symposium
Date:9/7/2007

ORLANDO, Fla., Sept. 7 /PRNewswire/ -- Daniel B. Yarosh, PhD, President and CEO AGI Dermatics, will deliver the keynote presentation at the 11th Annual Sunscreen Symposium today in Lake Buena Vista, FL. The multi-day gathering (September 6th-9th) of cosmetic chemists is sponsored by the Florida chapter of the Society of Cosmetic Chemists. Dr. Yarosh will present "Beyond Sunscreens: DNA Repair and Photoaging" to the more than 250 cosmetic chemists from around the U.S. and throughout the world who are scheduled to attend.

"Photoaging in skin is an extremely complex process and the genomic revolution has given us tools to understand UV-induced damage at the cellular level," said Dr. Yarosh. "Events such as the Sunscreen Symposium provide a forum in which we can share knowledge and ideas with colleagues, and further the sunscreen advancements around the world."

Dr. Yarosh, widely recognized as a pioneer in the science of DNA repair, is the author of more than 100 scientific papers and two dozen patents. He is an active participant in international photobiology societies and the New York biotechnology community.

AGI Dermatics founded by Dr. Yarosh in 1985, has emerged as a world leader in DNA repair technology for skin and is best known for developing Dimericine(R) (T4N5), a drug in testing for treating patients with skin cancers and pre-cancers. The U.S. Food & Drug Administration recently granted Fast Track designation for Dimericine for treatment of solar and ultraviolet photosensitivity in patients with Xeroderma Pigmentosum (XP), a rare genetic disorder that blocks the body's natural ability to repair DNA damage caused by ultraviolet light.

AGI Dermatics is also the developer of Remergent, a doctor-dispensed skincare line based on the science of DNA repair.

AGI Dermatics is the bio-pharmaceutical laboratory that has led the research of DNA repair of the skin for more than 20 years. Founded by Daniel B. Yarosh, PhD, AGI Dermatics specializes in skin photobiology, dedicating research and development to DNA repair, solar impact on the immune system, and cell-signaling in skin. The company's application of groundbreaking active ingredients and meticulously engineered liposome delivery systems is validated in controlled clinical studies and published in dozens of peer-reviewed scientific and medical journals. http://www.agiderm.com


'/>"/>
SOURCE AGI Dermatics
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Siemens health services president calls IT benefits unassailable
2. Wisconsin IT association names Gee president, CEO
3. Merge Healthcare promotes Bowers to president
4. Quintessence Biosciences names new president
5. VanderSanden appointed president of AT&T Wisconsin
6. Merge president steps down in wake of shareholder suits
7. Milwaukees PointOne appoints new president and CEO
8. Cars.com president slated for Milwaukee event
9. Sonic Foundry names new senior vice president
10. MyWeather names new president, marketing officer
11. At Berbee, president replaces founder as CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... in the development of a new orally administered treatment for Alzheimer’s disease (AD), ... CEO John Didsbury states, “As we seek to uniquely treat the metabolic dysfunctions ...
(Date:3/27/2017)... -- Cousins Properties (NYSE: CUZ ) announced today ... signed a 10-year, approximately 125,000 square-foot lease at Corporate Center, ... the Westshore submarket of Tampa, FL. ... Corporate Center for their new location in Tampa ... executive officer of Cousins Properties. "Amgen is a cutting-edge global ...
(Date:3/27/2017)... 2017  Perthera,s Chief Bioinformatics Officer and research faculty ... , Ph.D., will be speaking at the American Medical ... March 27, 2017, she will be speaking on the ... Research and Care" (from 10:30 a.m. – 12:00 p.m. ... be a participant in the "Making Precision Oncology Data ...
(Date:3/27/2017)... , March 27, 2017  Trovagene, Inc. (NASDAQ: TROV), ... Chief Executive Officer, Bill Welch , will be ... 2017 at 9:00 AM EDT at the Essex House ... Welch, and Chief Scientific Officer, Mark Erlander , ... during the conference.   The presentation will be ...
Breaking Biology Technology:
(Date:3/9/2017)... SAN FRANCISCO and MOUNTAIN VIEW, ... Zipongo , "Eating Well Made Simple," and 23andMe ... to help guide better food choices.  Zipongo can now ... only their food preferences, health goals and biometrics, but ... to certain food choices. Zipongo,s personalized food ...
(Date:3/2/2017)... , March 2, 2017 Summary ... understand Perrigo and its partnering interests and activities since 2010. ... Read ... Deals and Alliance since 2010 report provides an in-depth insight ... life sciences companies. On demand company reports are ...
(Date:3/1/2017)... 2017  Aware, Inc. (NASDAQ: AWRE), a leading supplier ... P. Moberg has resigned, effective March 3, 2017, ... Officer and Treasurer of Aware citing a desire to ... member of the Board of Directors of Aware. ... Officer and co-President, General Counsel has been named Chief ...
Breaking Biology News(10 mins):